Cita APA

Gohr, K., Hamacher, A., Engelke, L. H., & Kassack, M. U. (2017). Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38. BMC Cancer.

Chicago Style Citation

Gohr, Katharina, Alexandra Hamacher, Laura H. Engelke, i Matthias U. Kassack. "Inhibition of PI3K/Akt/mTOR Overcomes Cisplatin Resistance in the Triple Negative Breast Cancer Cell Line HCC38." BMC Cancer 2017.

Cita MLA

Gohr, Katharina, Alexandra Hamacher, Laura H. Engelke, i Matthias U. Kassack. "Inhibition of PI3K/Akt/mTOR Overcomes Cisplatin Resistance in the Triple Negative Breast Cancer Cell Line HCC38." BMC Cancer 2017.